TTechnology Read More Pembrolizumab Hits Nearly 90% Response Rate in Desmoplastic MelanomaAugust 15, 2025 Melanoma: © David A Litman – stock.adobe.com Pembrolizumab (Keytruda) elicited a clinical response in nearly 90% of patients…
HHealth Read More Study Reveals Missed Opportunities for Surgical Prevention of Ovarian CancerAugust 15, 2025 Illustration of ovarian cancer: © blueringmedia – stock.adobe.com One-fourth of patients with high-grade serous carcinoma (HGSC) may have…
TTechnology Read More EBUS-TBNA Lung Biopsies Appear Safer, Adequate for Biomarker TestingAugust 14, 2025 Illustration of lungs: © yodiyim – stock.adobe.com Bronchoscopy-guided biopsies provide adequate samples for comprehensive biomarker testing while being…